ReviewClinical imaging
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
Review in Clinical imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 32 citations in OpenAlex.
- Cerebrospinal fluid protein levels are elevated 100 times in a Leptomeningeal metastasis patient: a case report and literature review.Frontiers in neuroscience · 2023Article
- Differences of spinal cord gadolinium enhancement features of neuromyelitis optica spectrum disorder and long-segment degenerative cervical myelopathy.Frontiers in neurology · 2023Article
- [Inflammatory diseases of the central nervous system].Der Radiologe · 2021Article
- Brain miliary enhancement.Neuroradiology · 2020Review
- Neuromyelitis Optica Spectrum Disorder Attack Triggered by Herpes Zoster Infection.Multiple sclerosis international · 2020Article
- Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.The British journal of radiology · 2018Article
- Pattern Recognition of the Multiple Sclerosis Syndrome.Brain sciences · 2017Review
- Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.Neurology(R) neuroimmunology & neuroinflammation · 2017Article
- Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.AJNR. American journal of neuroradiology · 2017Article
- Headache in Neuromyelitis Optica.Current pain and headache reports · 2017Review
- Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.Neurology(R) neuroimmunology & neuroinflammation · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 3 countries.
Funding
Abstract
Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system that usually presents with acute myelitis and/or optic neuritis. Recently, some brain magnetic resonance imaging findings have been described in NMO that are important in the differential diagnosis. Pencil-thin, leptomeningeal, and cloud-like enhancement may be specific to NMO. These patterns are usually seen during relapses. Recognizing these lesions and enhancement patterns may expedite the diagnosis and allows early effective treatment. The purpose of this article is to review the latest knowledge and to share our experience with the contrast enhancement patterns of NMO brain lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.